Zika and dengue virus agonists for transmission-blocking
Zika and dengue virus agonists for transmission-blocking
批准号:
9469995
负责人:
George Dimopoulos
金额:
$20.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-12-15 至 2019-11-30
关键词:
AedesAgonistAntibodiesArbovirusesBiological AssayBiologyBloodCRISPR/Cas technologyComputer Retrieval of Information on Scientific Projects DatabaseCulicidaeDataDengueDengue InfectionDengue VirusDevelopmentFertilityFutureGene DeletionGene SilencingGene Transfer TechniquesGenesGoalsImpairmentInfectionInstitutionIntegration Host FactorsKnock-outKnowledgeLiteratureLongevityMediatingMethodologyMidgutModelingNutritionalPharmaceutical PreparationsPrincipal InvestigatorRNA InterferenceResearchResearch InfrastructureResistanceRoleSalivaSystemTechnologyTestingTimeTimeLineTissuesTransgenic OrganismsVirusVirus DiseasesWorkZIKV infectionZika Virusbasedisorder controlexperiencefeedingfitnessfunctional genomicsnovelpermissivenessscreeningsmall moleculetransmission processvectorvector mosquitoviral transmission
中文摘要
首席研究员研究的长期目标是阐明蚊子载体与寨卡病毒(ZIKV)和登革热病毒(DENV)之间的相互作用,以确定适合制定疾病控制策略的传播阻断靶点。在通过载体的过程中,病毒与蚊子中肠和其他组织进行密切的相互作用,依赖于许多蚊子衍生的激动剂(宿主因子)。ZIKV和DENV可以在载体中通过基因编辑的激动剂缺失、通过RNA干扰的耗尽或通过抗体的阻断/干扰/抑制而受损。因此,研究用于疾病控制的病毒激动剂的一个明显优势是它们可以通过多种手段靶向。最近在伊蚊中开发的基于CRISPR/CAS9的基因编辑为通过基因缺失研究激动剂功能提供了新的和有前景的机会,并可用于开发新的ZIKV和DENV控制策略。在这里,我们将重点关注10种病毒激动剂,以评估它们在疾病控制方面的潜力,并进一步了解它们与ZIKV和DENV感染的关系。在目的1中,我们将验证6种推定的DENV激动剂在Ae中的ZIKV阻断潜力。使用RNAi介导的基因沉默对埃及伊蚊进行了研究。在目标2中,我们将开发CRISPR/CAS9介导的条件血粉诱导的中肠特异性基因KO蚊子,用于选择的ZIKV和DENV激动剂。在目标3中,我们将评估这些KO Ae。埃及品系对病毒感染的抗性以及它们在蚊子寿命和繁殖力方面的适合性影响。
英文摘要
The long-term goal of the principal investigator’s research is to elucidate the interactions between the mosquito vector and Zika virus (ZIKV) and Dengue virus (DENV), to identify transmission-blocking targets suitable for the development of disease control strategies. During their journey through the vector, the viruses engage in intimate interactions with the mosquito midgut and other tissues, relying on numerous mosquito-derived agonists (host factors). ZIKV and DENV can be impaired in the vector by agonist deletion through gene editing, depletion through RNA interference, or blocking / interference / inhibition through antibodies. Hence, an obvious advantage of studying virus agonists for disease control is that they can be targeted through multiple means. The recently developed CRISPR/CAS9-based gene editing in Aedes mosquitoes provide new and promising opportunities for the study of agonist function through gene deletion, and could be used to develop novel ZIKV and DENV control strategies. Here we will focus on 10 virus agonists to assess their potential for disease control and further our knowledge of their involvement in ZIKV and DENV infection. In Aim 1, we will validate 6 putative DENV agonists for ZIKV blocking potential in Ae. aegypti using RNAi-mediated gene silencing. In Aim 2, we will develop CRISPR/CAS9-mediated conditional bloodmeal-inducible midgut-specific gene KO mosquitoes for selected ZIKV and DENV agonists. In Aim 3, we will assess these KO Ae. aegypti lines for resistance to virus infection and their fitness impact in terms of mosquito longevity and fecundity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of gene-drive systems for population modification on malaria vector mosquitoes
-
批准号:10658710
-
项目类别:
-
资助金额:$109.21万
-
财政年份:2023
-
负责人:George Dimopoulos
-
依托单位:
Complete Plasmodium falciparum infection cycle model
-
批准号:10592599
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2022
-
负责人:George Dimopoulos
-
依托单位:
Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of mice
-
批准号:10589090
-
项目类别:
-
资助金额:$80.78万
-
财政年份:2021
-
负责人:George Dimopoulos
-
依托单位:
Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of mice
-
批准号:10393036
-
项目类别:
-
资助金额:$81.95万
-
财政年份:2021
-
负责人:George Dimopoulos
-
依托单位:
Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of mice
-
批准号:10182487
-
项目类别:
-
资助金额:$84.43万
-
财政年份:2021
-
负责人:George Dimopoulos
-
依托单位:
Bacteriophage modulation of mosquito microbiota
-
批准号:9979027
-
项目类别:
-
资助金额:$20.47万
-
财政年份:2020
-
负责人:George Dimopoulos
-
依托单位:
Aedes antiviral RNAi pathway
-
批准号:10289713
-
项目类别:
-
资助金额:$75.6万
-
财政年份:2018
-
负责人:George Dimopoulos
-
依托单位:
Aedes antiviral RNAi pathway
-
批准号:10054161
-
项目类别:
-
资助金额:$76.27万
-
财政年份:2018
-
负责人:George Dimopoulos
-
依托单位:
Exploring Anopheles micro RNAs for malaria control
-
批准号:8845308
-
项目类别:
-
资助金额:$20.25万
-
财政年份:2015
-
负责人:George Dimopoulos
-
依托单位:
Exploring Anopheles micro RNAs for malaria control
-
批准号:9086223
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2015
-
负责人:George Dimopoulos
-
依托单位:
MicroRNA regulation of Anopheles immunity to Plasmodium
-
批准号:9055063
-
项目类别:
-
资助金额:$68.19万
-
财政年份:2015
-
负责人:George Dimopoulos
-
依托单位:
MicroRNA regulation of Anopheles immunity to Plasmodium
-
批准号:9181380
-
项目类别:
-
资助金额:$66.67万
-
财政年份:2015
-
负责人:George Dimopoulos
-
依托单位:
Targeting dengue in the mosquito with small molecules
-
批准号:8839070
-
项目类别:
-
资助金额:$5.82万
-
财政年份:2014
-
负责人:George Dimopoulos
-
依托单位:
Targeting dengue in the mosquito with small molecules
-
批准号:8645613
-
项目类别:
-
资助金额:$74.23万
-
财政年份:2012
-
负责人:George Dimopoulos
-
依托单位:
Targeting dengue in the mosquito with small molecules
-
批准号:8342925
-
项目类别:
-
资助金额:$80.98万
-
财政年份:2012
-
负责人:George Dimopoulos
-
依托单位:
Targeting dengue in the mosquito with small molecules
-
批准号:8461517
-
项目类别:
-
资助金额:$72.36万
-
财政年份:2012
-
负责人:George Dimopoulos
-
依托单位:
The JAK-STAT pathway in anti-dengue defense
-
批准号:8071113
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2010
-
负责人:George Dimopoulos
-
依托单位:
The JAK-STAT pathway in anti-dengue defense
-
批准号:7962725
-
项目类别:
-
资助金额:$16.4万
-
财政年份:2010
-
负责人:George Dimopoulos
-
依托单位:
Dscam function in innate immunity
-
批准号:8277381
-
项目类别:
-
资助金额:$32.47万
-
财政年份:2010
-
负责人:George Dimopoulos
-
依托单位:
Dscam function in innate immunity
-
批准号:7984461
-
项目类别:
-
资助金额:$30.88万
-
财政年份:2010
-
负责人:George Dimopoulos
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: